Hôpital Necker Enfants Malades
Paris, 75015, France
NCT Number: NCT01312727
The aim of this study is to identify families with hereditary chronic tubulointerstitial renal diseases , characterize the phenotype and screen for mutations in known genesis (UMOD, REN, TCF2, NPHP1). Genome wide analysis will be performed in families without mutations identified.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Paris, 75015, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
phenotype and genotype analysis, biological analysis
Other names: phenotype and genotype analysis, biological analysis
Time frame: after 18 months
Number of patients/families with mutations in known genes responsible for HTIN
Time frame: at 18 months
Assistance Publique - Hôpitaux de Paris
Other
Phenotypical and Genetic Characterization of Adult Hereditary Chronic Tubulointerstitial Renal Diseases
Acronym: NTIH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06650111
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Paris, France
View Trial DetailsNCT05499312
Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Shatin, Hong Kong
View Trial DetailsNCT05665699
Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Birmingham, Alabama, United States
View Trial DetailsNCT06229145
Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Birmingham, Alabama, United States
View Trial Details